Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
An error occurred in the February 2007 issue of the journal (Iannone F, Trotta F, Monteccuco C, Giacomelli R, Galeazzi M, Matucci-Cerinic M, et al. Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects. Ann Rheum Dis 2007;66:249–52.) The correct spelling of the third author’s name is Montecucco C.